HCPCS code J9153: Daunorubicin/cytarabine, per 1 mg daunorubicin2026 Medicare rate & RVUs in California

CMS doesn’t publish an office rate for J9153 in California.

Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.

What J9153 covers

This code represents a liposomal combination of daunorubicin and cytarabine, given by intravenous infusion. The combination is used in adults with newly diagnosed therapy-related acute myeloid leukemia or acute myeloid leukemia with myelodysplasia-related changes. Oncology practices and hospital-based infusion services typically report the drug code for the amount administered, alongside the applicable chemotherapy administration service.

CMS excludes J9153 from the physician fee schedule under status E. When Medicare covers the drug, it is treated as a Part B drug, with payment generally based on CMS quarterly Average Sales Price drug pricing files; coverage is left to the Medicare contractor’s judgment. One HCPCS unit represents 1 mg of daunorubicin in the liposomal combination and the corresponding 2.27 mg of cytarabine. Report units based on the amount administered, using that paired dose as the unit.

This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.

Where J9153 pays more and less in California

The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.

29 of 29 payment localities

How the J9153 rate is calculated

Each of J9153’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.

Payment rules and modifiers for J9153

J9153 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.

J9153 compared with similar codes

How to choose

J9150Daunorubicin injectionPer 10 mg

Use J9153 for the liposomal daunorubicin-cytarabine combination. J9150 identifies daunorubicin injection alone.

96413Chemo IV infusionInitial drug, first hour

J9153 identifies the drug and its dose units; 96413 identifies an initial chemotherapy infusion administration service, when applicable.

Codes related to J9153

Related codes aren’t interchangeable: bill the code that matches the service performed.

Where these rates come from

FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.

CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027

Open CMS sourceHow we calculate rates